Data from @rheum_covid global registry: "race & ethnicity associated with poor health outcomes in #rheumaticdisease patients with #COVID19 in US. @MilenaGianfran et al. Important work highlighting health disparities in COVID-19. Abs#0006 #ACR20 @RheumNow https://t.co/4e3gAUJ4q1

Impact of #COVID19 on #rheum patients in Arab region @Nellziade -2163 pts -Negative effects on continuity of care, persistence on chronic meds & #mentalhealth -Recommends better communication & drug availability for pt benefit Abs#0004 #ACR20 @RheumNow https://t.co/EGmBmcleAr

Abs#0012 at #ACR20 shows #rheumatology patients in the US had significant changes to healthcare and access to meds during #COVID19. https://t.co/2x7j47WiZL For patients & clinicians: what do you consider to be the most important impact on rheumatology due to COVID-19? @RheumNow

• Experiences of Patients with Rheumatic Diseases in the US During the Early Mont…

Huge congrats @kmdsilvaMD on your @RheumResearch Scientist Development Award- "Respiratory Complications of #COVID19 in Rheumatic Diseases." Be sure to also join Kristin tomorrow as she presents at the #ACR20 plenary! @MGH_ClinEpi https://t.co/LamvuWTMIW

Delighted to be reporting for @RheumNow at #ACR20! Here, I review the last year in #infection in #rheumaticdiseases (it’s been a busy one!) and highlight just a few of the abstracts on infections (incl #COVID19), #vaccination and #immunogenicity. Enjoy! https://t.co/x1pzyOICAF

• Infection and Rheumatic Diseases: A New Dawn | RheumNow

COVID-19 use of dexamethasone- why does it work? When to use it ?Is it hyperferrintemic sepsis? Vs early MAS vs? More data needed but this why rheumatologists are needed!!! @RheumNow #ACR20 thank you dr. Rubin! https://t.co/MvQJGqsqu2

What is your top concern about the SARS-Co-V2 vaccine for rheum patients? @RheumNow #ACR20